These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 12113089)

  • 21. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
    Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
    Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for survival in metastatic renal cell carcinoma: update 2008.
    Bukowski RM
    Cancer; 2009 May; 115(10 Suppl):2273-81. PubMed ID: 19402065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing natural history of renal cell carcinoma.
    Pantuck AJ; Zisman A; Belldegrun AS
    J Urol; 2001 Nov; 166(5):1611-23. PubMed ID: 11586189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Are immunotherapy and chemotherapy in metastatic renal cell cancer out?].
    Schmitz-Dräger BJ
    Urologe A; 1992 Jul; 31(4):213-4. PubMed ID: 1514204
    [No Abstract]   [Full Text] [Related]  

  • 26. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
    Kim HL; Seligson D; Liu X; Janzen N; Bui MH; Yu H; Shi T; Belldegrun AS; Horvath S; Figlin RA
    J Urol; 2005 May; 173(5):1496-501. PubMed ID: 15821467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic factors in kidney cancer].
    Patard JJ
    Prog Urol; 2007 Feb; 17(1 Suppl 1):139-43. PubMed ID: 17571637
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma.
    Hannisdal E; Bostad L; Grøttum KA; Langmark F
    Eur J Surg Oncol; 1989 Aug; 15(4):333-6. PubMed ID: 2759251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Localized and locally advanced renal cell carcinoma: method of outcome prognosis].
    Serniak IuP
    Urol Nefrol (Mosk); 1998; (1):32-5. PubMed ID: 9532944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
    Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
    Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic biomarkers in renal cell carcinoma.
    Jiang Z
    Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic factors in renal cell carcinoma].
    Letang N; Cabaniols L; Pouessel D; Robert M; Iborra F; Culine S; Patard JJ; Guiter J; Thuret R
    Bull Cancer; 2009 Apr; 96(4):475-84. PubMed ID: 19357021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic markers in renal cell carcinoma.
    Ljungberg B
    Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
    Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Staging and follow-up of renal cell carcinoma].
    Rouvière O; Brunereau L; Lyonnet D; Rouleau P
    J Radiol; 2002 Jun; 83(6 Pt 2):805-22, discussion 823-4. PubMed ID: 12218854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of metastatic renal cell carcinoma: current trends.
    Mohammed A; Shergill I; Little B
    Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
    Lam JS; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.